Hint mode is switched on Switch off
For swift navigation between sections

Organization: Rocket Pharmaceuticals
LEI 549300R7VV82YUIN4Y93

Organization name
Rocket Pharmaceuticals Inc. (formerly: Inotek Pharmaceuticals Corporation)
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
-

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The company was founded in 1999 and is headquartered in Lexington, Massachusetts.

Awards

News

06/05/2024 Rocket Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
25/03/2024 Rocket Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
26/02/2024 Rocket Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
13/02/2024 Rocket Pharmaceuticals: Other Events, Financial Statements And Exhibits
07/12/2023 Rocket Pharmaceuticals: Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers; Compensatory Arrangements Of Certain Officers
All organization news

Documentation

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    549300R7VV82YUIN4Y93
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001281895

Credit and ESG Ratings

Macroeconomic Indicators - Rocket Pharmaceuticals

Registration is required to get access.